Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05736029 · ClinicalTrials.gov registry record
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
A clinical trial of Healthy and Non-Small Cell Lung Cancer, sponsored by OncoHost.
- Recruiting
- Registry status
- 350
- Enrollment target
- 1
- Study location
NCT05736029 is a study of Healthy and Non-Small Cell Lung Cancer that is actively recruiting participants, run by OncoHost. The registered enrollment target is 350 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05736029, a study of Healthy and Non-Small Cell Lung Cancer, is actively recruiting participants, sponsored by OncoHost.
- RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this exploratory study is understand the mechanisms of response to immunotherapy in Non-Small Cell Lung Cancer patients. The investigators are going to search for correlation between specific biological features and response to immunotherapy, and to use those associations for developing an algorithm enabling to identify patients that could benefit from the immune check inhibitor based anti cancer treatment. Patients will provide biological samples before and during their treatment, and clinical data will be collected.
Conditions Studied
Interventions
- OTHER blood, stool and tissue samples collection
Study Locations (1)
Texas
- Baylor Scott and White Research Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2028-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05736029
The ClinicalTrials.gov registry entry for NCT05736029 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (46% lower). The listed sponsor is OncoHost, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which blood, stool and tissue samples collection is the first listed.
NCT05736029 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05736029 about?
NCT05736029 is a clinical study titled "Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics". The goal of this exploratory study is understand the mechanisms of response to immunotherapy in Non-Small Cell Lung Cancer patients. The investigators are going to search for correlation between specific biological features and response to immunotherapy, and to use those associations for developing...
What is the current status of trial NCT05736029?
This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2022-11-07. Estimated completion is 2028-06-30.
What conditions does trial NCT05736029 study?
This clinical trial studies the following conditions: Healthy, Non-Small Cell Lung Cancer.
What interventions are being tested in trial NCT05736029?
The interventions under investigation include: blood, stool and tissue samples collection (OTHER).
Who is sponsoring clinical trial NCT05736029?
This trial is sponsored by OncoHost, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05736029 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.